Stay on Top of These 6 Blood Tests to Make Sure You're Monitoring Your Health
Having your blood drawn might not be much fun, but regular diagnostic tests of your blood can detect diseases early for treatment and give your doctor and medical providers critical information about how well your body is functioning.
The proper frequency of these blood tests depends on your age and personal health status -- the most important thing is to ask your doctor which tests you need and when you need them.
With all the different types of blood tests out there, it's good to go into your health care provider with a sense of what the most popular tests do and how they work. To help you out, we spoke with doctors for their expert insights about some important blood tests you may want to talk to your doctor about.
1. Complete blood count
The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood cells and platelets.
Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is "recommended for individuals of all ages as part of a routine health examination or when symptoms suggest a potential health issue."
Dr. Maria Knöbel, medical director of Medical Cert UK, agrees that this foundational test is appropriate for many patients. She says the test is ideal for anyone undergoing a routine health check-up. Still, she advises that you may want to get it if you're "experiencing symptoms like persistent fatigue, unexplained bruising or frequent infections."
A CBC blood test can indicate lots of things, including:
Allergies
Anemia
Certain cancers
Heart disease
Immune system disorders
Infection
Inflammation
Iron deficiency
Leukemia
Low platelets (can affect blood clotting)
Risk of clotting and bleeding
Vitamin deficiency
Mandal explains that each lab may have slight variations for what they consider "normal" test results. The ranges typically accepted as normal for adults are:
Red blood cells: 4.5-5.9 million cells per microliter (men), 4.1-5.1 million cells per microliter (women)
White blood cells: 4,500-11,000 cells per microliter
Hemoglobin: 13.8-17.2 grams per deciliter (men), 12.1-15.1 grams per deciliter (women)
Hematocrit: 40.7%-50.3% (men), 36.1%-44.3% (women)
Platelets: 150,000-450,000 platelets per microliter
2. Lipid panel
Lipids are fats and fatty substances in your blood. One type of lipid is cholesterol, which is used as a source of energy. Too much "bad" cholesterol (low-density lipoprotein or LDL) can damage your heart.
You may need to get this test if you have cardiovascular disease or other risk factors. Mandal states this test is essential for anyone "at risk of cardiovascular diseases, including those with a family history of heart disease, smokers, people with hypertension or those who are overweight."
Knöbel explains that a lipid panel measures total cholesterol and also breaks it down into HDL/LDL:
Triglycerides
LDL (bad cholesterol)
HDL (good cholesterol)
She says, "Elevated LDL levels are associated with an increased risk of heart disease, while high HDL levels are generally protective. Elevated triglycerides can also indicate a risk for heart disease and may be associated with other conditions like diabetes."
The normal parameters for a lipid panel in adults are:
Total cholesterol: Less than 200 mg/dL
LDL cholesterol: Less than 100 mg/dL
HDL cholesterol: 40 mg/dL or higher (men), 50 mg/dL or higher (women)
Triglycerides: Less than 150 mg/dL3. Basic metabolic panel
The basic metabolic panel (BMP) measures what Knöbel calls "critical aspects of your body's chemistry." This includes glucose, calcium and electrolytes such as sodium, potassium and bicarbonate. The test also looks for kidney function indicators, such as blood urea nitrogen and creatinine.
"Glucose levels provide insight into blood sugar control," Knöbel explains. "Electrolyte imbalances can reveal issues related to dehydration, kidney disease or metabolic imbalances. Abnormal calcium levels can indicate issues with bone health or parathyroid function." BMP is often part of a routine exam. It also may be recommended for patients with diabetes or kidney disease or those at risk for these conditions.
The results of your BMP could indicate:
Dehydration
Deteriorating bone health
Diabetes
Hypertension
Kidney disease
For adults, Mandal says the normal ranges for results of this test are:
Bicarbonate: 23-30 mEq/L
Blood urea nitrogen (BUN): 7-20 mg/dL
Calcium: 8.5-10.2 mg/dL
Chloride: 96-106 mEq/L
Creatinine: 0.6-1.3 mg/dL
Glucose: 70-99 mg/dL (fasting)
Potassium: 3.5-5.0 mEq/L
Sodium: 135-145 mEq/L
4. Hemoglobin A1C
The Hemoglobin A1C test, also called the HbA1c, is a blood test that measures your average blood sugar level over the past 2-3 months. Mandel explains that it's primarily used to diagnose and monitor diabetes and pre-diabetes. If you're overweight, have symptoms of diabetes, have a family history of diabetes or are over the age of 45, the doctor says you may also want to get this test. A daily sugar test gives you a short-term view of your blood sugar level. On the other hand, this test is a long-term view of how well your body is managing glucose.
Getting an HbA1c test could reveal a few things about your health:
Diabetes
Poor blood sugar control (higher risk of diabetes-related complications)
Pre-diabetes
Normal ranges for test results are:
Normal: Less than 5.7%
Pre-diabetes: 5.7% to 6.4%
Diabetes: 6.5% or higher
5. Thyroid function tests
If you are experiencing fatigue, weight changes, irregular heartbeat, hair loss or mood swings, you may want to get a thyroid function test. Typically prescribed only if you display symptoms such as those previously mentioned, this test measures the amount of thyroid-stimulating hormone in your blood. Your doctors can use the results to see how well your thyroid (a small, hormone-releasing gland in the front of your throat) is functioning. Mandal tells us this test is commonly included in routine health screenings, especially in women older than 60.
Your blood test may indicate:
High TSH levels/hypothyroidism (an underactive thyroid)
Low TSH levels/hyperthyroidism (an overactive thyroid)
Abnormal levels of T3 and T4 (other thyroid disorders)
Doctors typically consider the following normal ranges for test results in adults:
TSH levels: 0.4-4.0 mIU/L
Free T4 levels: 0.8-1.8 ng/dL
Free T3 levels: 2.3-4.2 pg/mL
6. 25-hydroxy vitamin D
According to Mount Sinai, a hospital system in New York, some older patients can benefit from getting a 25-hydroxy test to check their vitamin D levels. People who are older than 65, have osteoporosis, get limited sun exposure and/or have celiac disease, Crohn's disease or ulcerative colitis may benefit from the test.
Most people get ample vitamin D from the sun. Both skin production and gut absorption of the vitamin declines as we age. It's important to find out if you don't have enough vitamin D because it helps with everything from bone health to immunity and energy levels.
The 25-hydroxy vitamin D will reveal two things:
25 hydroxy vitamin D3 (cholecalciferol)
25 hydroxy vitamin D2 (ergocalciferol)
There is some disagreement among doctors about what a healthy range is for vitamin D but one generally accepted range is 20 and 40 ng/mL.
Blood test FAQs
Why are blood tests important?
Blood tests are important because they can help doctors monitor your health and the effectiveness of treatments. They can also help doctors diagnose different medical conditions and determine the best treatment path.
If my blood tests are normal, could I still have cancer?
Routine blood tests may not be able to detect most types of cancer so even if your blood tests come back normal, you could still have cancer. Cancers also require additional diagnostic and laboratory testing for confirmation. If you're concerned about a certain type of cancer, discuss this with your doctor.
Which blood tests need to be fasting?
According to Harvard Health, fasting is often advised before tests such as glucose (blood sugar) and triglycerides, the latter of which is part of the cholesterol or lipid panel. Consult your doctor if you're confused about how long you should fast before your blood tests.
The bottom line
It's always important to discuss your health and any related concerns with your doctor before requesting any type of test. Based on your personal situation and health plan, your doctor may request blood work not on this list or say that you don't need some of the above tests.
As a general rule, many people can benefit from CBC, lipid panel, BMP and hemoglobin A1C even without any symptoms. Also, thyroid function and vitamin D tests should be considered if you experience any symptoms. If you're older, you may also want to talk to your physician about your vitamin D absorption.
If your labs are abnormal, you may need additional screening and more frequent repeat labs. If your labs are normal, these labs may only need to be repeated once a year while doing your annual exam with your primary doctor.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
U.S. Supreme Court orders review over religious challenge to New York abortion law
The U.S. Supreme Court on Monday ordered a lower court in New York to reevaluate whether some religious organizations should be excluded from a state mandate that requires employers to provide employee health care plans that include abortion coverage. The ruling from the high court said the case, Diocese of Albany v. Harris, should be sent back to New York courts to be reviewed again in light of an earlier unanimous Wisconsin case related to the Catholic Church groups being denied state tax exemptions. The justices pointed to the Wisconsin case because the New York case poses similar issues about states exempting religious employers and faith-based groups, The Associated Press reported. The New York case stems from a 2017 state mandate that requires health insurance plans provided by employers to include abortion coverage for situations that include rape and incest. The state mandate includes a religious exemption for institutions, but not for religious-affiliated groups. It was challenged by Catholic and Anglican nuns, Catholic dioceses, Christian churches and other faith organizations. They argued the religious exemption is so narrow that it violates the freedom of religion protected under the First Amendment. The most recent order from the Supreme Court is the second time the case has reached the justices after being litigated for years. After the state adopted the mandate in 2017, religious groups challenged it in state court. The appeals court upheld the regulation and the state refused to exempt religious organizations. In 2021, the religious groups appealed the state's ruling to the U.S. Supreme Court. Justices asked New York to reconsider based on its ruling in another case involving religion, Fulton v. Philadelphia. State courts found the Fulton decision was inapplicable to the situation, prompting the groups to bring it to the Supreme Court again. The religious liberty law firm Becket noted in a release that New York's exemption doesn't currently apply to some organizations, including the Carmelite Sisters for the Aged and Infirm and the Teresian Nursing Home because they 'serve the elderly and dying regardless of religious affiliation.' 'New York wants to browbeat nuns into paying for abortions for the great crime of serving all those in need,' Becket Vice President and senior counsel Eric Baxter said in a statement.' Following the Supreme Court's Monday order, the case is headed back to the New York Court of Appeals.
Yahoo
an hour ago
- Yahoo
Ionis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to Retire
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 10 biotech stocks screaming a buy. On June 12, the company announced the upcoming retirement of Richard Geary, Ph.D., its executive vice president and chief development officer, effective January 2026. Holly Kordasiewicz, Ph.D., currently senior vice president of neurology, will take over the role. Geary has been with Ionis since 1995 and played a pivotal role in bringing six medicines to regulatory approval, including the company's first independently commercialized drug, TRYNGOLZA. A biotechnologist pouring liquid into a test tube and analyzing its components in a lab. Dr. Kordasiewicz, who joined Ionis in 2011, brings over 20 years of experience in R&D, particularly in neurology. She leads the company's neurology program, covering treatments for conditions such as Alzheimer's disease, Angelman syndrome, and Alexander disease. Her work has also contributed to key partnered programs with Biogen, including the development of QALSODY® and IONIS-MAPTRx. As Dr. Geary transitions out of his role, he will continue as a strategic consultant through 2026 to ensure continuity. Ionis leadership praised both Geary's legacy and Kordasiewicz's appointment as a pivotal step in driving the company's commitment to developing transformational therapies for patients with serious diseases. Ionis Pharmaceuticals, Inc. is a U.S.-based commercial-stage biotech company specializing in RNA-targeted therapies. Its approved products include TRYNGOLZA for FCS, WAINUA, and TEGSEDI for ATTRv-PN, SPINRAZA for spinal muscular atrophy, QALSODY for ALS, and WAYLIVRA for rare lipid disorders. The company has a robust pipeline, including late-stage programs like Olezarsen (for hypertriglyceridemia), Donidalorsen (for hereditary angioedema), and Zilganerse (for Alexander disease), along with several mid-stage treatments for neurological and metabolic conditions. Ionis also collaborates with leading pharma firms, including Biogen, GSK, AstraZeneca, Novartis, Roche, and Metagenomi, expanding its reach in developing transformative RNA therapies. While we acknowledge the potential of IONS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None.
Yahoo
an hour ago
- Yahoo
Acadia Pharmaceuticals (ACAD) Conducts Inducement Awards to Attract and Retain Top Talent
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is one of the 10 biotech stocks screaming a buy. On June 17, the company moved to attract and retain top talent by granting inducement awards to 41 employees. Under the 2024 Inducement Plan, the company will award the employees non-qualified stock options of 187,664 shares and 89.582 restricted stock units designed to attract and retain talent. A pharmacist in a pharmacy preparing a prescription medication for a patient suffering from Fibromyalgia. The move to offer inducement awards is part of Acadia Pharmaceuticals' push to secure top-skilled professionals essential for its neuroscience projects. It expects the awards to ensure employees are incentivized to contribute to the long-term objectives expected to lead to sustained growth and innovation. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharma company dedicated to advancing treatments for central nervous system disorders and rare diseases. Its key products include NUPLAZID, approved for Parkinson's disease psychosis, and DAYBUE. While we acknowledge the potential of ACAD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None. 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
